Main competitors
Capi.($) Investor ESG MSCI Fundamentals Financial revisions Global Valuation Visibility Consensus
6.71B - - - - -
72.14B
BBB
52.16B
AA
46.76B
BBB
42.91B
A
28.25B
AA
20.19B
AAA
19.53B
AA
19.26B -
BBB
- -
16.66B
AA
14.02B -
BBB
- - -
13.13B
CCC
13.21B -
BB
- -
11.33B -
BBB
- -
11.3B -
BB
- - -
10.46B
BBB
-
8.75B -
B
- -
7.56B -
BB
- - -
7.33B
A
6.73B
BB
Average 21.42B
A
Weighted average by Cap.
A
Biopharmaceuticals